Navigation Links
Immunotech Completes Merger Acquisition
Date:3/30/2009

GLENDALE, Calif., March 30 /PRNewswire-FirstCall/ -- Immunotech Laboratories, Inc.(Pink Sheets: IMMB) has completed a reverse merger with a public shell company and has restructured its position through a 100 to 1 reverse split of stock. The company has issued 60 million authorized shares bringing the total number of issued and outstanding shares to 60,555,688 shares trading under NASDAQ OTC.PK Exchange ticker symbol IMMB.

Immunotech Laboratories, Inc. has indefinite licensing rights of the Irreversible Pepsin Fraction (IPF) peptide molecule for the specific treatment of the HIV/AIDS indication. IPF has demonstrated to have both fusion inhibitor and immunomodulator capabilities during in vitro studies with no viral resistance. This provides opportunities for patients that have already shown resistance to one or more antiretroviral therapies.

Immunotech Laboratories' core competency is in developing novel therapeutic molecules for the treatment of HIV/AIDS and a research pipeline with potential treatments for pre-natal and pediatric HIV/AIDS patients, subsequently developing a Preventive HIV Vaccine. The U.S. Patent office has granted full patent rights for IPF under patent number 7479538. Efforts are done to complete the pre-clinical studies in order to position the company's regulatory efforts in obtaining approval to initiate clinical phase I studies projected to start the 4th quarter of 2010. The company is in preparation to initiate efforts of acquiring fast track status designation from the FDA.

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Immunotech Laboratories, Inc. from time to time in its periodic reports filed with the SEC. IPF is not approved by the US Food and Drug Administration or by any comparable reg
'/>"/>

SOURCE Immunotech Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... TX (PRWEB) September 02, 2014 The Dream2Walk ... presenting Music4Miracles on Sept. 14th, 2014 during Spinal Cord Injury ... McKinney, Aubrey Lynn England, and Chuck Ligon. Linear Automotive will ... and Gasser show. , Doors open at 2pm. The car ... which includes one free pass to the concert. There will ...
(Date:9/2/2014)... Sept. 2, 2014 (HealthDay News) -- Two new studies ... suggests that 6-year-olds who were breast-fed have a lower ... bottle-fed infants, while the other finds a similar trend ... the "many benefits of breast-feeding in the immediate newborn ... Hill Hospital in New York City. She was not ...
(Date:9/2/2014)... HealthDay Reporter TUESDAY, Sept. 2, ... weight loss by blocking a certain nerve linked to appetite ... obese patients. Using electric impulses to block the vagus ... to suppress feelings of hunger. And, they did, just not ... blocks the nerve that connects the brain to the gut ...
(Date:9/2/2014)... Steven Reinberg HealthDay Reporter ... the Ebola outbreak continues to overwhelm health-care workers in ... States and the United Nations called on Tuesday for ... of the often-fatal virus. Dr. Thomas Frieden, director ... said that without a greater global commitment in resources ...
(Date:9/2/2014)... sleep apnea, tonsillectomies, hearing loss, head and neck ... in Orlando, FL, September 21-24, at the 2014 ... Academy of OtolaryngologyHead and Neck Surgery Foundation (AAO-HNSF), ... head and neck physicians in the world. , ... released today, and are available online at ...
Breaking Medicine News(10 mins):Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 2Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 3Health News:More Global Help Needed to Fight Ebola Outbreak 2Health News:More Global Help Needed to Fight Ebola Outbreak 3
... The European Association of Urology (EAU) and Europa ... prostate cancer, have entered into an,affiliated partnership as ... improve,patient awareness in Europe with regards to urological ... "Thanks to this unique,EAU affiliated partnership, Europa Uomo ...
... a series of clinical trials in order to assess ... the application of personalised vaccines produced from healthy and ... designed to combat glioblastomas, one of the most aggressive ... to participating patients combined with the standard, first-line treatment ...
... time, so do knees, internal injuries, study finds, , MONDAY, ... warrior who likes to hit the basketball court or hockey ... of physical activity boost the risk of internal knee damage ... the injuries occurred in middle-age people who showed no symptoms ...
... , Red Cross ... name of others , WASHINGTON, Nov. 30 In spite ... support charities in two ways, with 62 percent planning to dig deep ... with others about donating to charity instead of buying them a gift, ...
... , KALAMAZOO, Mich., Nov. 30 Stryker ... agreement to acquire privately held Ascent Healthcare Solutions, Inc. ... devices in the U.S. , Under the terms of ... million in an all cash transaction. The closing is conditioned ...
... Here,s how the House and Senate bills stack up , ... bills moving through the U.S. Congress differ in a number ... in the number of uninsured Americans. , Legislation approved by ... to 96 percent of Americans. The Senate is preparing to ...
Cached Medicine News:Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3
(Date:9/2/2014)... The Pharmaceutical Care Management Association (PCMA), the national association ... lawsuit in Iowa federal court ... law that restricts tools used by PBMs to lower ... The law—HF 2297—forces PBMs to overpay ... Maximum Allowable Cost (MAC) lists that keep generic drug ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com announces ... in its catalogue: Acute Heart Failure ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute Heart ... Summary GlobalData,s clinical trial report, "Acute ... provides data on the Acute Heart Failure clinical ...
(Date:9/2/2014)... Spanje, September 2, 2014 ... AF Registry bij het ESC CONGRESS 2014 ... patiënten met risico op beroerte in de ... Gegevens van bijna 12.500 patiënten ingeschreven in ... Fibrillation (GARFIELD-AF), een innovatief, onafhankelijk initiatief op ...
Breaking Medicine Technology:Lawsuit Challenges Iowa Health Mandate that Forces Employers to Pay More for Prescription Drugs 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 2Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 3Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 4Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 5Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 6Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 7Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 8Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 9Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 10
... Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide ... a conference call on Thursday, November 12, 2009, at ... operating performance for the first quarter ended September 30, ... and marketing activities. , Corgenix invites all those interested ...
... 3 On-Q-ity, a next-generation oncology diagnostics company ... that it has closed a $21 million series ... MDV-Mohr Davidow Ventures and included Bessemer Venture Partners, ... http://www.newscom.com/cgi-bin/prnh/20070702/AQM026LOGO ) , On-Q-ity is developing ...
Cached Medicine Technology:Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
... has been designed so the surgeon can ... tissue away from the operative surface. It ... without stay-sutures or assistance. This controlled versatility ... to do other tasks, which will broaden ...
... The PowerPro® Battery System is a ... line of powered surgical instruments. The PowerPro ... software controlled battery powered instrument available on ... power system specifically designed to meet the ...
... GE OEC, the market leader ... decades of imaging experience and advanced ... with its latest entry, the MiniView ... extremity imaging has the workstation components ...
Lightweight & portable, compact station. Accurate and speedy measurement, auto-shot function, AI measuring function, focusing indicator....
Medicine Products: